IQVIA’s white paper outlines how digital transformation is reshaping clinical trials through AI, automation, and real-time data integration. Key trends include AI-driven drug discovery with Phase I success rates of 80–90% vs 55–65% traditionally, faster patient recruitment using predictive models, and decentralized trials cutting costs by 2–3% with 4x ROI. Digital tools like ePRO, wearables, and telehealth improve patient engagement and data quality. Sponsors benefit from scenario-based planning, real-time monitoring, and reduced “white space” between phases. Future-ready digital models promise greater efficiency, compliance, and patient-centric trial environments.

Join for free to read